Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia
- 23 September 2013
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 53 (1) , 80-87
Abstract
Background. Alopecia is a frequently occurring side effect of chemotherapy that often can be prevented by cooling the scalp during the infusion. This study compared effects and costs of scalp cooling with usual general oncological care, i.e. purchasing a wig or head cover. Material and methods. Scalp-cooled patients (n = 160) were compared with non-scalp-cooled patients (n = 86) at 15 Dutch hospitals. Patients were enrolled prior to anthracycline and/or taxane-based chemotherapy for several types of cancer between 2007 and 2008. Cost-effectiveness of scalp cooling compared with that of usual care was determined by the ratio of costs to quality adjusted life years (QALYs). Costs for scalp cooling (machines and nursing time), hair dressers, wigs and head covers were estimated from a societal perspective. QALYs were measured using the Short Form-36. Results. Scalp cooling reduced the use of a wig or head cover by 40%, but wigs were still purchased unnecessarily by 38% of scalp-cooled patients. Average societal costs decreased therefore only by €269 per patient due to scalp cooling (p = 0.02). Given the eligibility for scalp cooling at the time, the insignificant difference in QALYs resulted from a balance of the benefits for those patients with successful scalp cooling and those without success. For the Dutch, given the generally accepted threshold of willingness to pay for a QALY (between €20 000 and €40 000), scalp cooling was cost-effective, therefore justifying the choice of scalp cooling or purchasing a wig or head cover. Conclusion. Given the right indication, cost-effectiveness might be improved further by postponing wig and head cover purchases, by improving scalp cooling efficacy, as well as using the scalp cooling capacity more intensively.Keywords
This publication has 25 references indexed in Scilit:
- Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopeciaSupportive Care in Cancer, 2012
- Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling RegistryActa Oncologica, 2012
- Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: A willingness to pay studyLung Cancer, 2010
- Impact of alopecia and scalp cooling on the well‐being of breast cancer patientsPsycho-Oncology, 2010
- The Dutch tariff: results and arguments for an effective design for national EQ‐5D valuation studiesHealth Economics, 2006
- A comparison of the EQ‐5D and SF‐6D across seven patient groupsHealth Economics, 2004
- Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: A pilot studyPsycho-Oncology, 2002
- Changes in self-concept and body image during alopecia induced cancer chemotherapySupportive Care in Cancer, 1997
- The ‘Utility’ of the Visual Analog Scale in Medical Decision Making and Technology Assessment: Is It an Alternative to the Time Trade-off?International Journal of Technology Assessment in Health Care, 1996
- Chemotherapy-Induced AlopeciaSouthern Medical Journal, 1993